The love of a lifetime: 5-HT in the cardiovascular system (Q46407178)

21 December 2017

title

The love of a lifetime: 5-HT in the cardiovascular system (English)

1 reference

21 December 2017

1 reference

Stephanie W Watts

1

1 reference

21 December 2017

language of work or name

1 reference

27 August 2008

1 reference

21 December 2017

American Journal of Physiology - Regulatory, Integrative and Comparative Physiology

published in

1 reference

21 December 2017

volume

296

1 reference

21 December 2017

issue

2

1 reference

21 December 2017

page(s)

R252-6

1 reference

21 December 2017

Appetite-suppressant drugs and the risk of primary pulmonary hypertension. International Primary Pulmonary Hypertension Study Group

cites work

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.90676.2008

Modern views on an ancient chemical: serotonin effects on cell proliferation, maturation, and apoptosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.90676.2008

Upregulation of arterial serotonin 1B and 2B receptors in deoxycorticosterone acetate-salt hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.90676.2008

Plasma serotonin levels and the platelet serotonin transporter

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.90676.2008

Evidence that blood pressure reduction by serotonin antagonists is related to alpha receptor blockade in spontaneously hypertensive rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.90676.2008

Vascular reactivity of isolated perfused kidneys from male and female spontaneously hypertensive rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.90676.2008

Recent advances in understanding serotonin regulation of cardiovascular function

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.90676.2008

5-Hydroxytryptamine lowers blood pressure in normotensive and hypertensive rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.90676.2008

The role of 5-HT on the cardiovascular and renal systems and the clinical potential of 5-HT modulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.90676.2008

Identification of enteramine, the specific hormone of the enterochromaffin cell system, as 5-hydroxytryptamine.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.90676.2008

Studies on the effect of MDMA ('ecstasy') on the body temperature of rats housed at different ambient room temperatures

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.90676.2008

Long-term serotonin administration induces heart valve disease in rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.90676.2008

Molecular, pharmacological and functional diversity of 5-HT receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.90676.2008

5-hydroxytryptamine receptors in the human cardiovascular system

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.90676.2008

5-hydroxytryptamine and the pulmonary circulation: receptors, transporters and relevance to pulmonary arterial hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.90676.2008

The existence of a local 5-hydroxytryptaminergic system in peripheral arteries.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.90676.2008

The fenfluramine metabolite (+)-norfenfluramine is vasoactive

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.90676.2008

The serotonin transporter is present and functional in peripheral arterial smooth muscle

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.90676.2008

5-hydroxytryptamine in the cardiovascular system: focus on the serotonin transporter (SERT).

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.90676.2008

Evidence for possible involvement of 5-HT(2B) receptors in the cardiac valvulopathy associated with fenfluramine and other serotonergic medications

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.90676.2008

5-Hydroxytryptamine(2B) receptor function is enhanced in the N(omega)-nitro-L-arginine hypertensive rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.90676.2008

Serotoninergic mechanisms in hypertension. Focus on the effects of ketanserin

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.90676.2008

Cardiovascular responses produced by 5-hydroxytriptamine:a pharmacological update on the receptors/mechanisms involved and therapeutic implications.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.90676.2008

5-HT in systemic hypertension: foe, friend or fantasy?

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.90676.2008

5-Hydroxytryptamine2B receptor mediates contraction in the mesenteric artery of mineralocorticoid hypertensive rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.90676.2008

10.1152/AJPREGU.90676.2008

21 January 2018

Identifiers

DOI

1 reference

21 December 2017

PubMed ID

18753260

1 reference

21 December 2017